Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 7
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Use of carfilzomib in second-line therapy and beyond for relapsed multiple myeloma
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
11,449 | Dovepress* | 11,449+ | 1,028 | 12,477 | |
Totals | 11,449 | 1,028 | 12,477 | ||
*Since 19 July 2017 |
View citations on Google Scholar